GZMB and neoplasm: Flow cytometric analysis demonstrated that provision of hetIL-15 resulted in higher proportion of tumor-infiltrating CD8+ and CD4+ T lymphocytes, as well as NK cells harboring GzmB in comparison to untreated mice (figure 3B–D, respectively).